What may be the markers of the male equivalent of polycystic ovary syndrome?

January 2004 in “ Physiological Research ”

Michaela Dušková, I Cermáková, Martin Hill, Markéta Vaňková, P. Šamalíková, L Stárka

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on doi.org →

Discuss this study in the Community →

Research cited in this study

5 / 5 results

research Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome

4809 citations , January 2004 in “Fertility and Sterility”

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

research Androgenetic Alopecia and Prostate Cancer: Findings from an Australian Case-Control Study

21 citations , June 2002 in “PubMed”

The conclusion is that there might be a link between certain types of baldness and prostate cancer, which could be due to shared hormonal pathways.

research Androgenetic Alopecia in Men and Women

77 citations , March 2001 in “Clinics in Dermatology”

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

research Biochemical Roles of Testosterone and Epitestosterone to 5α-Reductase as Indicators of Male-Pattern Baldness

47 citations , January 2001 in “Journal of Investigative Dermatology”

High testosterone to epitestosterone ratio in hair could predict male-pattern baldness.

research A Prospective Study of the Prevalence of Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain

491 citations , July 2000 in “The Journal of Clinical Endocrinology and Metabolism”

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.